Dr. Goodman will discuss clinical concerns regarding common thrombotic issues. He will review the causes and the utility of hypercoaguable states. He will discuss the limits of diagnostic testing for idiopathic thrombosis and talk about the treatment options for this condition.
This activity reviews diagnostic and therapeutic approaches for patients with atrial arrhythmias, including supraventricular tachycardia, atrial flutter and atrial fibrillation. Faculty will discuss the safety and efficacy of catheter ablation compared with pharmacologic therapy, as well as recent data on how risk factor modification (hypertension, obesity, exercise, sleep apnea, alcohol) can be used as a means to reduce the recurrence rate for atrial fibrillation.
In this case presentation, Dr. James Underberg, MD, Clinical Assistant Professor of Medicine at NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease and Director, Bellevue Hospital Lipid Clinic, shares strategies for identifying Heterozygous Familial Hypercholesterolemia (HeFH) in a patient with a lifelong history of elevated cholesterol. He also summarizes data for recently approved PCSK9 inhibitors for treating patients with HeFH.
In this audio webcast, two recognized cardiologist experts, Dr. James de Lemos and Dr. Benjamin Scirica, will review the management of stable ischemic heart disease (SIHD). Specifically, they will address the following needs: 1) efficient diagnostic testing and assessment of risk in SIHD patients; 2) enhanced quality of life for SIHD patients through more prudent use of antianginal drugs; and 3) improved clinical decision-making regarding when to revascularize SIHD patients.
Dr. Andrew Bomback uses a case vignette to illustrate the work-up of a patient who presents with secondary hypertension in order to differentiate between hypertensive urgency and hypertensive emergency and formulate appropriate interventions.
The aim of this program is to compare safety outcomes of patients with 12 week versus 4 week warfarin monitoring as well assess warfarin dosing in patients with a stable warfarin dose.
In this activity, Dr. Blaine will review the current epidemiology of hypertension in the United States and discuss how advocating for self-measured blood pressure monitoring can help the patients in your practice. He will discuss aspects of choosing devices, clinical support strategies and provide practical advice on applying this program in your practice.
Hypertension is a chronic condition, with long term management strategies. On occasion, however, rather than evaluating and managing chronic hypertension, the clinical is faced with a hypertensive crisis. Understanding how and when to respond to such crises is of paramount importance in order to reduce morbidity and mortality in such situations. Dr. Watson will discuss how to perform an early evaluation of clinical symptoms and evaluation for end-organ damage as it is critical to determine the appropriate management.